Annual Total Long Term Liabilities
$8.13 M
+$4.34 M+114.68%
December 31, 2023
Summary
- As of February 7, 2025, IKNA annual total long term liabilities is $8.13 million, with the most recent change of +$4.34 million (+114.68%) on December 31, 2023.
- During the last 3 years, IKNA annual total long term liabilities has fallen by -$232.99 million (-96.63%).
- IKNA annual total long term liabilities is now -96.63% below its all-time high of $241.12 million, reached on December 31, 2020.
Performance
IKNA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$5.52 M
-$914.00 K-14.21%
September 30, 2024
Summary
- As of February 7, 2025, IKNA quarterly total long term liabilities is $5.52 million, with the most recent change of -$914.00 thousand (-14.21%) on September 30, 2024.
- Over the past year, IKNA quarterly long term liabilities has dropped by -$35.20 million (-86.45%).
- IKNA quarterly long term liabilities is now -97.71% below its all-time high of $241.12 million, reached on December 31, 2020.
Performance
IKNA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
IKNA Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +114.7% | -86.5% |
3 y3 years | -96.6% | +80.5% |
5 y5 years | -93.4% | +80.5% |
IKNA Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -36.5% | +114.7% | -86.5% | +80.5% |
5 y | 5-year | -96.6% | +114.7% | -97.7% | +80.5% |
alltime | all time | -96.6% | +114.7% | -97.7% | +80.5% |
Ikena Oncology Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $5.52 M(-14.2%) |
Jun 2024 | - | $6.43 M(-11.5%) |
Mar 2024 | - | $7.27 M(-10.6%) |
Dec 2023 | $8.13 M(+114.7%) | $8.13 M(-80.0%) |
Sep 2023 | - | $40.72 M(+1232.5%) |
Jun 2023 | - | $3.06 M(-10.9%) |
Mar 2023 | - | $3.43 M(-9.5%) |
Dec 2022 | $3.79 M | $3.79 M(-43.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $6.64 M(-20.0%) |
Jun 2022 | - | $8.30 M(-12.3%) |
Mar 2022 | - | $9.46 M(-26.2%) |
Dec 2021 | $12.81 M(-94.7%) | $12.81 M(-54.0%) |
Sep 2021 | - | $27.87 M(-13.0%) |
Jun 2021 | - | $32.02 M(-11.1%) |
Mar 2021 | - | $36.00 M(-85.1%) |
Dec 2020 | $241.12 M(+95.8%) | $241.12 M |
Dec 2019 | $123.14 M | - |
FAQ
- What is Ikena Oncology annual total long term liabilities?
- What is the all time high annual total long term liabilities for Ikena Oncology?
- What is Ikena Oncology annual total long term liabilities year-on-year change?
- What is Ikena Oncology quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Ikena Oncology?
- What is Ikena Oncology quarterly long term liabilities year-on-year change?
What is Ikena Oncology annual total long term liabilities?
The current annual total long term liabilities of IKNA is $8.13 M
What is the all time high annual total long term liabilities for Ikena Oncology?
Ikena Oncology all-time high annual total long term liabilities is $241.12 M
What is Ikena Oncology annual total long term liabilities year-on-year change?
Over the past year, IKNA annual total long term liabilities has changed by +$4.34 M (+114.68%)
What is Ikena Oncology quarterly total long term liabilities?
The current quarterly long term liabilities of IKNA is $5.52 M
What is the all time high quarterly long term liabilities for Ikena Oncology?
Ikena Oncology all-time high quarterly total long term liabilities is $241.12 M
What is Ikena Oncology quarterly long term liabilities year-on-year change?
Over the past year, IKNA quarterly total long term liabilities has changed by -$35.20 M (-86.45%)